ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

EGFR Targeted Liposomal PROTAC Assisted With Epigenetic Regulation as an Efficient Strategy for Osimertinib-Resistant Lung Cancer Therapy.

Dongyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.